rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Eric Swayze

EVP Research

Company insider

Files Form 4 as: EVP Research, Ionis Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
139
Buys
0
Sells
27
Bought
$0
Sold
$16.4M
Companies
1
Companies where not an officer
0
First trade
2 Jan 2020
Last trade
16 Oct 2026
Last filed
19 Oct 2026

Companies traded

Where they are an officer
IONS Ionis PharmaceuticalsOfficer · Biotechnology · last 16 Oct 20260 buys · 27 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Oct 2026filed 19 Oct 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$2,30853 at $43.54filing
15 Oct 2026filed 19 Oct 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Code M—125 at $0.00filing
15 Oct 2026filed 19 Oct 2026IONS Ionis Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—125 at $0.00filing
25 Jun 2026filed 26 Jun 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$839K10,602 at $79.18filing
25 Jun 2026filed 26 Jun 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$839K10,602 at $79.18filing
27 Feb 2026filed 3 Mar 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Code J$13K256 at $48.87filing
27 Feb 2026filed 3 Mar 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Code J$13K256 at $48.87filing
13 Feb 2026filed 13 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$770K9,435 at $81.56filing
13 Feb 2026filed 13 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$509K6,207 at $82.07filing
13 Feb 2026filed 13 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$770K9,435 at $81.56filing
13 Feb 2026filed 13 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$509K6,207 at $82.07filing
30 Jan 2026filed 2 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$512K6,179 at $82.93filing
30 Jan 2026filed 2 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$512K6,179 at $82.93filing
29 Jan 2026filed 2 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Code A—11,991 at $0.00filing
29 Jan 2026filed 2 Feb 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Code A—11,991 at $0.00filing
16 Jan 2026filed 20 Jan 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$745K9,884 at $75.34filing
16 Jan 2026filed 20 Jan 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$3,72349 at $75.97filing
16 Jan 2026filed 20 Jan 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$745K9,884 at $75.34filing
16 Jan 2026filed 20 Jan 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Sold$3,72349 at $75.97filing
15 Jan 2026filed 20 Jan 2026IONS Ionis PharmaceuticalsBiotechnologySEC FORM 4 Code M—21,366 at $0.00filing

Sectors

Health Care27

Buys in green, sells in red, by the company’s sector.

Related people

Shannon L. DeversEVP, Chief Human Resources Ofc · EVP, Chief Human Resources Ofc at Ionis Pharmaceuticals, filing Form 4 there in the last year
Brian BirchlerEVP, Corp and Development Ops · EVP, Corp and Development Ops at Ionis Pharmaceuticals, filing Form 4 there in the last year
Patrick R. O'NeilEVP CLO & General Counsel · EVP CLO & General Counsel at Ionis Pharmaceuticals, filing Form 4 there in the last year
Brett P. MoniaChief Executive Officer · Chief Executive Officer at Ionis Pharmaceuticals, filing Form 4 there in the last year
C. Frank BennettEVP, Chief Scientific Officer · EVP, Chief Scientific Officer at Ionis Pharmaceuticals, filing Form 4 there in the last year
Michael R. HaydenDirector · Also traded IONS in the last 90 days